2007
DOI: 10.1016/j.carpath.2006.10.004
|View full text |Cite
|
Sign up to set email alerts
|

Role of inflammation in nonrheumatic, regurgitant heart valve disease. A comparative, descriptive study regarding apolipoproteins and inflammatory cells in nonrheumatic heart valve disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 31 publications
0
6
1
Order By: Relevance
“…On the other hand, we found a much lesser involvement of inflammatory cells than reported in aortic valves [22]. Although some degree of lymphocytes and macrophages infiltration in non-rheumatic regurgitant mitral valves has been described, it is significantly lower than in calcific aortic stenosis [30,31], suggesting differential pathophysiological mechanisms with a more prominent role of VICs and VECs in mitral valve disease than in calcific aortic degeneration -which presents features more similar to the atherosclerotic process. The prevalence in our patients of coronary artery disease, defined as coronary stenosis ≥50% of the lumen, was 21%, mostly subclinical, since only 6% had previously had myocardial infarction.…”
Section: Discussioncontrasting
confidence: 55%
“…On the other hand, we found a much lesser involvement of inflammatory cells than reported in aortic valves [22]. Although some degree of lymphocytes and macrophages infiltration in non-rheumatic regurgitant mitral valves has been described, it is significantly lower than in calcific aortic stenosis [30,31], suggesting differential pathophysiological mechanisms with a more prominent role of VICs and VECs in mitral valve disease than in calcific aortic degeneration -which presents features more similar to the atherosclerotic process. The prevalence in our patients of coronary artery disease, defined as coronary stenosis ≥50% of the lumen, was 21%, mostly subclinical, since only 6% had previously had myocardial infarction.…”
Section: Discussioncontrasting
confidence: 55%
“…The prevalence of oxidized lipids in RFH leaflets also supports the conclusion that these valves are undergoing early CAVD processes, rather than myxomatous degeneration, a condition that is also characterized by GAG enrichment and collagen disruption. In addition to aortic valve myxomatous degeneration being rare in humans who do not also have congenital abnormalities or inflammation-related disease, 53 nonrheumatic myxomatous human aortic valves tend to not be highly enriched in oxidized lipids, 54 nor is hypercholesterolemia believed to be a risk factor for myxomatous aortic valve disease.…”
Section: Insights Into Early Cavd Provided By Adult Rfh Swinementioning
confidence: 99%
“…32,91,98 In canine valves, mast cells were slightly increased in the perimeter of pathologic areas of diseased valves suggesting a potential role of mast cells in this disease. Interestingly, the human myxomatous valve is prone to develop bacterial endocarditis.…”
Section: Inflammatory Cellsmentioning
confidence: 96%
“…7A and B). 98 Several researchers believe that myofibroblasts or a-actin positive VIC may be a major phenotype that mediates degeneration. A study on human myxomatous valve disease suggested that a-actin positive VIC might be an activated VIC phenotype which play a role in producing catabolic enzymes and ECM.…”
Section: Valve Interstitial Cellsmentioning
confidence: 99%